Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
3.480
-0.270 (-7.20%)
At close: Nov 5, 2026, 4:00 PM EST
3.493
+0.013 (0.36%)
After-hours: Nov 5, 2026, 7:30 PM EST
Unicycive Therapeutics Employees
As of December 31, 2025, Unicycive Therapeutics had 22 total employees, including 21 full-time and 1 part-time employees. The number of employees decreased by 1 or 4.35% compared to the previous year. That makes Unicycive Therapeutics the 38,161st largest employer in the world and 5,479th in the United States.
Employees
22
Change (1Y)
-1
Growth (1Y)
-4.35%
Revenue / Employee
n/a
Profits / Employee
-$1,601,045
Market Cap
96.94M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 22 | -1 | -4.35% | 21 | 1 |
| Dec 31, 2024 | 23 | 9 | 64.29% | 22 | 1 |
| Dec 31, 2023 | 14 | 2 | 16.67% | 14 | 0 |
| Dec 31, 2022 | 12 | 3 | 33.33% | 12 | 0 |
| Dec 31, 2021 | 9 | 8 | 800.00% | 9 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunic | 100 |
| enGene Therapeutics | 82 |
| PMV Pharmaceuticals | 54 |
| OnKure Therapeutics | 45 |
| Milestone Pharmaceuticals | 38 |
| TuHURA Biosciences | 22 |
| PDS Biotechnology | 21 |
| Black Diamond Therapeutics | 21 |
UNCY News
- 1 day ago - Unicycive Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference - GlobeNewsWire
- 7 days ago - Kaplan Fox Alerts Investors: Lead Plaintiff Deadline for Unicycive Therapeutics, Inc. (UNCY) is November 2, 2026 - Newsfile Corp
- 14 days ago - What Does Unicycive Therapeutics, Inc.'s 39.1% Stock Drop Mean for Investors? The Law Offices of Howard G. - PRNewsWire
- 15 days ago - What Should Unicycive Therapeutics, Inc. Investors Know After 39.1% Stock Drop? The Law Offices of Frank R. - PRNewsWire
- 15 days ago - Unicycive Therapeutics announces FDA acceptance of resubmission of OLC NDA - TheFly
- 15 days ago - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027 - GlobeNewsWire
- 15 days ago - Kaplan Fox Urges Investors of Unicycive Therapeutics, Inc. (UNCY) to Seek a Leadership Role Before November 2, 2026 - Newsfile Corp
- 17 days ago - Kaplan Fox Encourages Unicycive Therapeutics, Inc. (UNCY) Investors Seeking Recovery to Contact the Firm Before November 2, 2026 - Newsfile Corp